Patients
Featured News and Projects
Sanford is first in nation to test new COVID-19 treatment
Sanford is the first site in the nation to enroll patients in a phase 1b trial of a new therapy developed by Sioux Falls-based SAB Biotherapeutics. The new therapy is designed to treat people with mild to moderate COVID-19 at an early stage.
Aspiring doctor values research experience at Sanford Lab
A University of South Dakota MD-PhD candidate has spent the last few years in the Baack Lab at Sanford Research to complete the PhD portion of his dual degree. Eli has received national recognition for his work studying heart development.
Sanford cancer clinical trial shows improved outcomes
From bench to bedside, Sanford's head and neck research team led a study incorporating an immunotherapy drug into the standard regimen for treating head and neck cancersOur Spotlight Programs
Centers
Sanford Research is home to four research centers. Each multidisciplinary center is defined by complementary scientific and technical expertise along with supporting resources to advance a thematic research goal. Thematic goals encompass: studying of complex behaviors and biological factors, improving the health of patients and communities using unique data-driven techniques, translating basic discoveries into clinical trials for humans, and enhancing children’s health research.
Sanford Health News
-
background-image
Sanford Lab adds 5,000 square feet to prepare for flu season
Expansion will allow for more flu and COVID-19 testing, with faster results
-
background-image
MD turns to world of data, helping patients in new ways
Sanford’s Dr. Murat Sincan looks at patterns of disease at Imagenetics, Research